Not applicableStudy completedNCT03140774What this trial is testingPersistence of the Immune Response After Immunisation With Ebola Virus VaccinesWho this might be right forEbola Virus Disease University of Oxford 126
Post-approval studies (Phase 4)Study completedNCT06038617What this trial is testingSafety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young ChildrenWho this might be right forFever After VaccinationFeverSeizures Fever Duke University 344
Post-approval studies (Phase 4)Active Not RecruitingNCT04083430What this trial is testingCytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D VaccinationWho this might be right forHealthyCytotoxicityYellow Fever Vaccination Reaction University of Aarhus 60
Post-approval studies (Phase 4)Looking for participantsNCT07158814What this trial is testingSafety of RSV Preventive Monoclonal AntibodyWho this might be right forFeverAdverse Event Following Immunisation Duke University 524
Post-approval studies (Phase 4)Study completedNCT01946594What this trial is testingClinical Immunization Safety Assessment (CISA) Project: Pilot Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After IIVWho this might be right forFever Duke University 41
Post-approval studies (Phase 4)Study completedNCT05028361What this trial is testingSimultaneous mRNA COVID-19 and IIV4 Vaccination StudyWho this might be right forQuality of LifeInjection Site ReactionAdverse Drug Event+1 more Duke University 348
Not applicableStudy completedNCT02212990What this trial is testingThe Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza VaccineWho this might be right forFever Duke University 104
Testing effectiveness (Phase 2)Study completedNCT03116802What this trial is testingYellow Fever Vaccine on Statin/ Non Statin SubjectsWho this might be right forYellow Fever VaccineYellow Fever Singapore General Hospital 37
Not applicableStudy completedNCT01765413What this trial is testingTraining Study to Characterize Biomarkers to Chickenpox and Yellow Fever VaccinesWho this might be right forHealthy University of Surrey 48
Large-scale testing (Phase 3)Active Not RecruitingNCT06007183What this trial is testingLong-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster VaccinationWho this might be right forChikungunya Virus Infection Bavarian Nordic 800
Early research (Phase 1)Study completedNCT02533791What this trial is testingA Booster Dose of Ad5-EBOV in Healthy Adults After Primary ImmunizationWho this might be right forEbola Virus Disease Jiangsu Province Centers for Disease Control and Prevention 110
Testing effectiveness (Phase 2)Study completedNCT04269265What this trial is testingThe Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever VaccinationWho this might be right forYellow Fever University of Minnesota 43
Not applicableLooking for participantsNCT06843226What this trial is testingA Study in Children and Teenagers to Learn if a TDV Dengue Vaccination Lowers the Chance of Hospital Stays for DengueWho this might be right forDengue Fever Takeda 70,000
Not applicableStudy completedNCT02911428What this trial is testingOpen Study of the Duration of Immunity After Vaccination With GamEvacWho this might be right forHemorrhagic Fever, Ebola Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 60
Post-approval studies (Phase 4)Study completedNCT05007041What this trial is testingSimultaneous RZV and aIIV4 VaccinationWho this might be right forPainQuality of LifeInjection Site Reaction+1 more Duke University 267
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05202288What this trial is testingImpact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy VolunteersWho this might be right forEbola Virus Disease ANRS, Emerging Infectious Diseases 132
Testing effectiveness (Phase 2)Study completedNCT02628444What this trial is testingImmunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of AgeWho this might be right forDengue FeverDengue Hemorrhagic Fever Sanofi Pasteur, a Sanofi Company 1,050
Not applicableStudy completedNCT05157191What this trial is testingSafety of Pediatric COVID-19 VaccinationWho this might be right forPainInjection Site ReactionAdverse Drug Event Duke University 299
Not applicableUnknownNCT03938597What this trial is testingInvestigation of Serious Adverse Events Following Vaccination Against Yellow Fever: Emphasis on Genetic Basis and Biological MarkersWho this might be right forDrug-Related Side Effects and Adverse Reactions The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 10
Not applicableStudy completedNCT01207583What this trial is testingPrevenar (PCV-7) Post-Licensure Safety Study In RussiaWho this might be right forHealthy Children After Vaccination Pfizer 100